These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15751341)

  • 21. The immune system, amyloid-beta peptide, and Alzheimer's disease.
    Weksler ME; Gouras G; Relkin NR; Szabo P
    Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equilibrium coverage fluctuations: a new approach to quantify reversible adsorption of proteins.
    Lüthgens E; Janshoff A
    Chemphyschem; 2005 Mar; 6(3):444-8. PubMed ID: 15799468
    [No Abstract]   [Full Text] [Related]  

  • 23. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zinc-amyloid beta interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species.
    Noy D; Solomonov I; Sinkevich O; Arad T; Kjaer K; Sagi I
    J Am Chem Soc; 2008 Jan; 130(4):1376-83. PubMed ID: 18179213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
    Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
    Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteolytic mechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer's disease.
    Vardy ER; Catto AJ; Hooper NM
    Trends Mol Med; 2005 Oct; 11(10):464-72. PubMed ID: 16153892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the saturation chain and head group charge of phospholipids in the interaction of hepatitis G virus synthetic peptides.
    Pérez S; Miñones J; Espina M; Alsina MA; Haro I; Mestres C
    J Phys Chem B; 2005 Oct; 109(42):19970-9. PubMed ID: 16853582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abeta-polyacrolein aggregates: novel mechanism of plastic formation in senile plaques.
    Seidler NW; Squire TJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):501-4. PubMed ID: 16081039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of trehalose on amyloid beta (29-40)-membrane interaction.
    Reddy AS; Izmitli A; de Pablo JJ
    J Chem Phys; 2009 Aug; 131(8):085101. PubMed ID: 19725634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isomerization of the Asp7 residue results in zinc-induced oligomerization of Alzheimer's disease amyloid beta(1-16) peptide.
    Tsvetkov PO; Popov IA; Nikolaev EN; Archakov AI; Makarov AA; Kozin SA
    Chembiochem; 2008 Jul; 9(10):1564-7. PubMed ID: 18506864
    [No Abstract]   [Full Text] [Related]  

  • 31. A beta oligomers - a decade of discovery.
    Walsh DM; Selkoe DJ
    J Neurochem; 2007 Jun; 101(5):1172-84. PubMed ID: 17286590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A peptide hairpin inhibitor of amyloid beta-protein oligomerization and fibrillogenesis.
    Yamin G; Ruchala P; Teplow DB
    Biochemistry; 2009 Dec; 48(48):11329-31. PubMed ID: 19877710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X-ray reflectivity study of a transcription-activating factor-derived peptide penetration into the model phospholipid monolayers.
    Tae G; Yang H; Shin K; Satija SK; Torikai N
    J Pept Sci; 2008 Apr; 14(4):461-8. PubMed ID: 17997505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Abeta interactions using ProteinChip technology.
    Giannakis E; Hung LW; Camacaro KP; Smith DP; Barnham KJ; Wade JD
    Methods Mol Biol; 2008; 494():71-86. PubMed ID: 18726569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production.
    Zhou S; Zhou H; Walian PJ; Jap BK
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7499-504. PubMed ID: 15890777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EPR study of the interactions between dendrimers and peptides involved in Alzheimer's and prion diseases.
    Klajnert B; Cangiotti M; Calici S; Majoral JP; Caminade AM; Cladera J; Bryszewska M; Ottaviani MF
    Macromol Biosci; 2007 Aug; 7(8):1065-74. PubMed ID: 17654761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-strand pairing and amyloid assembly.
    Liang Y; Pingali SV; Jogalekar AS; Snyder JP; Thiyagarajan P; Lynn DG
    Biochemistry; 2008 Sep; 47(38):10018-26. PubMed ID: 18759497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation.
    Schwarzman AL; Tsiper M; Gregori L; Goldgaber D; Frakowiak J; Mazur-Kolecka B; Taraskina A; Pchelina S; Vitek MP
    Amyloid; 2005 Dec; 12(4):199-209. PubMed ID: 16399644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the in situ structural and interfacial properties of the cationic hydrophobic heteropolypeptide, KL4, in lung surfactant bilayer and monolayer models at the air-water interface: implications for pulmonary surfactant delivery.
    Mansour HM; Damodaran S; Zografi G
    Mol Pharm; 2008; 5(5):681-95. PubMed ID: 18630875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P3 peptide, a truncated form of A beta devoid of synaptotoxic effect, does not assemble into soluble oligomers.
    Dulin F; Léveillé F; Ortega JB; Mornon JP; Buisson A; Callebaut I; Colloc'h N
    FEBS Lett; 2008 Jun; 582(13):1865-70. PubMed ID: 18474239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.